Enter your login e-mail to the account
Search
- Antiobesity drugs in the management of obese type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(5/2020, Topic of the year ) - Diabetes and obesity (diabesity) and COVID-19
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(4/2022, Topic of the year ) - Obesity and cardiovascular system
doc. MUDr. Štefan Farský, CSc., FESC
(5/2010, Review articles ) - Relative safety of new obesity drugs: latest evidence and patient management
MUDr. Ľubomíra Fábryová, PhD.
(2/2017, Topic of the year ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - NON-PHARMACOLOGICAL AND PHARMACOLOGICAL POSSIBILITIES IN THERAPY OF OBESE PATIENTS WITH METABOLIC SYNDROME
doc. MUDr. Boris Krahulec, CSc.
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Appraisal of the health ability for driving the motor vehicle with the relationship of the obstructive sleep apnea syndrome
MUDr. Imrich Mucska
(3/2016, Review articles ) - Epidemiology and health consequences of obesity
MUDr. Ľubomíra Fábryová, PhD.
(1/2015, Topic of the year ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - OBESITY AND TYPE 2 DIABETES (DIABESITY) – TWO CLOSELY RELATED, PREVENTABLE DISEASES IS THE THERAPY OF OBESITY TOOL FOR PREVENTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES?
MUDr. Ľubomíra Fábryová
(12/2006, Topic ) - THE EPIDEMIOLOGY OF OVERWIGHT AND OBESITY IN SLOVAKIA
doc. MUDr. Boris Krahulec, CSc., prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ján Lietava, CSc., MUDr. Milan Luliak, PhD., MUDr. Martin Čaprnda, PhD., MUDr. Ivar Vacula, PhD.
(3/2008, Topic ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic ) - CASE REPORT ON INFLUENCE OF SURGICAL TREATMENT OF OBESITY ON CARDIOMETABOLIC RISK
doc. MUDr. Pavol Holéczy, CSc., MUDr. Martin Bolek, MUDr. Rastislav Johanes
(3/2008, From practice )
- Prevention of cardiovascular risk and diabetes in schizophrenia patients: application of internet in clinical praxis
MUDr. Jiří Masopust, Ph.D., MUDr. Radovan Malý, Ph.D.
(5–6/2010, In short ) - Mental and cardiometabolic health in patients with schizofrenia
MUDr. Zuzana Vančová, PhD., Mgr. MUDr. Jozef Dragašek, PhD., MHA
(2/2022, Review articles )
- Health and psychosocial consequences of obesity in children and adolescents
MUDr. Irena Aldhoon Hainerová, Ph.D., RNDr. Hana Zamrazilová, Ph.D.
(3/2016, Review articles )
- MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles )
- Treatment and preventive use of zinc
MUDr. Peter Minárik, PhD., PharmDr. Daniela Mináriková, PhD.
(2/2015, Current pharmacotherapy )
- Current options for cardiovascular risk in patient with peripheral arterial disease
doc. MUDr. Denisa Čelovská, PhD., MUDr. Katarína Vlčková
(1/2022, Main topic )